Sale by Sun Kevin M of 514 shares of DermTech

DMTKDelisted Stock  USD 0.04  0.02  71.36%   
About 56% of all DermTech's institutional investors are looking to take a long position. The analysis of current outlook of investing in DermTech suggests that some traders are interested regarding DermTech's prospects. DermTech's investing sentiment shows overall attitude of investors towards DermTech.
  
Filed transaction by Dermtech Inc officer. General open market or private sale of non-derivative or derivative security

Read at macroaxis.com
DermTech insider trading alert for sale of common stock by Sun Kevin M, Chief Financial Officer, on 15th of March 2023. This event was filed by Dermtech Inc with SEC on 2023-03-15. Statement of changes in beneficial ownership - SEC Form 4

DermTech Fundamental Analysis

We analyze DermTech's financials across various querterly and yearly statements, indicators and fundamental ratios. We help investors to determine the real value of DermTech using virtually all public information available. We use both quantitative as well as qualitative analysis to arrive at the intrinsic value of DermTech based on its fundamental data. In general, a quantitative approach, as applied to this company, focuses on analyzing financial statements comparatively, whereas a qaualitative method uses data that is important to a company's growth but cannot be measured and presented in a numerical way.

Short Ratio

Short Ratio Comparative Analysis

DermTech is currently under evaluation in short ratio category among its peers. Short Ratio is typically used by traders and speculators to identify trends in current market sentiment for a particular equity instrument. In its simple terms this ratio shows how many days it will take all current short sellers to cover their positions if the price of a stock begins to rise.

DermTech Potential Pair-trading

One of the popular trading techniques among algorithmic traders is to use market-neutral strategies where every trade hedges away some risk. Because there are two separate transactions required, even if one position performs unexpectedly, the other equity can make up some of the losses. Below are some of the equities that can be combined with DermTech stock to make a market-neutral strategy. Peer analysis of DermTech could also be used in its relative valuation, which is a method of valuing DermTech by comparing valuation metrics with similar companies.
Check out Investing Opportunities to better understand how to build diversified portfolios. Also, note that the market value of any company could be closely tied with the direction of predictive economic indicators such as signals in estimate.
You can also try the Stocks Directory module to find actively traded stocks across global markets.

Other Consideration for investing in DermTech Stock

If you are still planning to invest in DermTech check if it may still be traded through OTC markets such as Pink Sheets or OTC Bulletin Board. You may also purchase it directly from the company, but this is not always possible and may require contacting the company directly. Please note that delisted stocks are often considered to be more risky investments, as they are no longer subject to the same regulatory and reporting requirements as listed stocks. Therefore, it is essential to carefully research the DermTech's history and understand the potential risks before investing.
Portfolio Center
All portfolio management and optimization tools to improve performance of your portfolios
Efficient Frontier
Plot and analyze your portfolio and positions against risk-return landscape of the market.
Money Flow Index
Determine momentum by analyzing Money Flow Index and other technical indicators
Portfolio Volatility
Check portfolio volatility and analyze historical return density to properly model market risk
Portfolio Suggestion
Get suggestions outside of your existing asset allocation including your own model portfolios
Sectors
List of equity sectors categorizing publicly traded companies based on their primary business activities